| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.9 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.9 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.038 | 0.9 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.9 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |